About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Biomarkers in Neuropsychiatry
›
top-articles
Biomarkers in Neuropsychiatry
2.2
(top 20%)
impact factor
53
(top 100%)
papers
447
(top 50%)
citations
10
(top 50%)
h
-index
2.3
(top 20%)
impact factor
88
all documents
556
doc citations
19
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Diagnostic biomarkers of Alzheimer’s disease: A state-of-the-art review
Biomarkers in Neuropsychiatry
2019
117
2
Psychomotor slowing in Schizophrenia: Implications for endophenotype and biomarker development
Biomarkers in Neuropsychiatry
2020
38
3
Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
Biomarkers in Neuropsychiatry
2019
37
4
Measures of Retinal Structure and Function as Biomarkers in Neurology and Psychiatry
Biomarkers in Neuropsychiatry
2020
32
5
Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
Biomarkers in Neuropsychiatry
2020
22
6
Neurophysiological biomarkers for schizophrenia therapeutics
Biomarkers in Neuropsychiatry
2020
18
7
Abnormal stress responsiveness and suicidal behavior: A risk phenotype
Biomarkers in Neuropsychiatry
2020
16
8
Retinal structural alterations in chronic versus first episode schizophrenia spectrum disorders
Biomarkers in Neuropsychiatry
2020
15
9
Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overview
Biomarkers in Neuropsychiatry
2020
14
10
Treatment response biomarkers in anxiety disorders: From neuroimaging to neuronally-derived extracellular vesicles and beyond
Biomarkers in Neuropsychiatry
2020
13
11
Biomarkers and neurobehavioral diagnosis
Biomarkers in Neuropsychiatry
2021
13
12
Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium
Biomarkers in Neuropsychiatry
2019
12
13
Diagnostic biomarkers in Alzheimer’s disease
Biomarkers in Neuropsychiatry
2021
12
14
Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder
Biomarkers in Neuropsychiatry
2019
10
15
Neurocircuitry of treatment in anxiety disorders
Biomarkers in Neuropsychiatry
2022
10
16
High delta and gamma EEG power in resting state characterise dementia in Parkinson’s patients
Biomarkers in Neuropsychiatry
2020
9
17
Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice
Biomarkers in Neuropsychiatry
2020
8
18
Hippocampal subfield alterations in schizophrenia: A selective review of structural MRI studies
Biomarkers in Neuropsychiatry
2020
8
19
Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features
Biomarkers in Neuropsychiatry
2020
8
20
Advancing translational research through the interface of digital phenotyping and neuroimaging: A narrative review
Biomarkers in Neuropsychiatry
2021
8
21
White matter pathology is shared across multiple psychiatric brain disorders: Is abnormal diffusivity a transdiagnostic biomarker for psychopathology?
Biomarkers in Neuropsychiatry
2020
7
22
Gene expression of methylation cycle and related genes in lymphocytes and brain of patients with schizophrenia and non-psychotic controls
Biomarkers in Neuropsychiatry
2021
7
23
The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior
Biomarkers in Neuropsychiatry
2021
7
24
What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis
Biomarkers in Neuropsychiatry
2022
7
25
Therapeutic implications of the serotonin transporter gene in depression
Biomarkers in Neuropsychiatry
2019
6
26
Cortical abnormalities and identification for first-episode schizophrenia via high-resolution magnetic resonance imaging
Biomarkers in Neuropsychiatry
2020
6
27
Tracking a dysregulated gut-brain axis with biomarkers of the microbiome
Biomarkers in Neuropsychiatry
2020
5
28
Antibodies against Group A Streptococcus, dopamine receptors, and ganglioside GM1 cross-react with a variety of food antigens, potentially interfering with biomarkers for PANS and PANDAS
Biomarkers in Neuropsychiatry
2020
5
29
Inter-device reliability of swept source and spectral domain optical coherence tomography and retinal layer differences in schizophrenia
Biomarkers in Neuropsychiatry
2021
5
30
Anterior-posterior axis of hippocampal subfields across psychoses: A B-SNIP study
Biomarkers in Neuropsychiatry
2021
5
31
Remote digital phenotyping in serious mental illness: Focus on negative symptoms, mood symptoms, and self-awareness
Biomarkers in Neuropsychiatry
2022
5
32
Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder
Biomarkers in Neuropsychiatry
2022
5
33
Change point analyses in prodromal Alzheimer’s disease
Biomarkers in Neuropsychiatry
2020
4
34
Reduced pituitary volume with relative T1 shortening correlates with behavior in Prader-Willi syndrome
Biomarkers in Neuropsychiatry
2021
4
35
Latent inhibition and its potential as a biomarker for schizophrenia
Biomarkers in Neuropsychiatry
2020
3
36
Dysregulation of complement system in neuropsychiatric disorders: A mini review
Biomarkers in Neuropsychiatry
2022
3
37
Fluid biomarkers for the diagnosis of neurodegenerative diseases
Biomarkers in Neuropsychiatry
2023
3
38
Biomarkers of Alzheimer’s disease: Past, present and future clinical use
Biomarkers in Neuropsychiatry
2023
3
39
Analysis of choroidal vessel density in patients with multiple sclerosis
Biomarkers in Neuropsychiatry
2021
2
40
Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis
Biomarkers in Neuropsychiatry
2021
2
41
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
Biomarkers in Neuropsychiatry
2021
2
42
Click-evoked auditory brainstem responses (ABRs) are intact in schizophrenia and not sensitive to cognitive training
Biomarkers in Neuropsychiatry
2022
2
43
Association between cholesterol and response to escitalopram and nortriptyline in patients with major depression: Study combining clinical and register-based information
Biomarkers in Neuropsychiatry
2022
2
44
Commentary: More research needed on predictive biomarkers related to clozapine treatment
Biomarkers in Neuropsychiatry
2019
1
45
Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkers
Biomarkers in Neuropsychiatry
2021
1
46
A pilot spectroscopy study of adversity in adolescents
Biomarkers in Neuropsychiatry
2021
1
47
Blood tests of brain function: Neuronal extracellular vesicles
Biomarkers in Neuropsychiatry
2022
1
48
The Carpenter-Strauss quest to save schizophrenia: How DSM shifted the construct from its historical core
Biomarkers in Neuropsychiatry
2023
1
49
Backtracing persistent biomarker shifts to the age of onset: A novel procedure applied to men’s and women’s white blood cell counts in post-traumatic stress disorder
Biomarkers in Neuropsychiatry
2021
0
50
Is a paired-stimuli configuration necessary to obtain typical evoked response differences in studies of psychosis? An MEG study
Biomarkers in Neuropsychiatry
2021
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.